FDA Grants QIDP and Fast Track Designations

CDTX: Cidara Therapeutics , Inc.
2018-09-25 08:00:00
FDA Grants QIDP and Fast Track Designations to Cidara Therapeutics’ Rezafungin Prophylaxis Development Program